Disease | small cell carcinoma |
Symptom | C0686377|central nervous system metastases |
Sentences | 3 |
PubMedID- 20740181 | We report for the first time a case of non-small cell lung cancer with central nervous system metastases harboring a rare egfr double activating mutation who showed a good clinical response to erlotinib, regardless of his poor performance status, as swallowing is not possible. |
PubMedID- 21030498 | Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic egfr mutations treated with gefitinib or erlotinib. |
PubMedID- 24765300 | Past medical history included non-small cell lung cancer with recurrent central nervous system metastases for which he was receiving whole brain radiation and temozolomide. |
Page: 1